IL140603A0 - Agents with an antidepressive effect - Google Patents

Agents with an antidepressive effect

Info

Publication number
IL140603A0
IL140603A0 IL14060399A IL14060399A IL140603A0 IL 140603 A0 IL140603 A0 IL 140603A0 IL 14060399 A IL14060399 A IL 14060399A IL 14060399 A IL14060399 A IL 14060399A IL 140603 A0 IL140603 A0 IL 140603A0
Authority
IL
Israel
Prior art keywords
agents
antidepressive effect
antidepressive
effect
Prior art date
Application number
IL14060399A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of IL140603A0 publication Critical patent/IL140603A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14060399A 1998-07-07 1999-07-02 Agents with an antidepressive effect IL140603A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830201A DE19830201A1 (de) 1998-07-07 1998-07-07 Mittel mit antidepressiver Wirkung
PCT/EP1999/004595 WO2000002542A2 (de) 1998-07-07 1999-07-02 Mittel mit antidepressiver wirkung, enthaltend pramipexol und ein weiteres antidepressivum

Publications (1)

Publication Number Publication Date
IL140603A0 true IL140603A0 (en) 2002-02-10

Family

ID=7873155

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14060399A IL140603A0 (en) 1998-07-07 1999-07-02 Agents with an antidepressive effect

Country Status (33)

Country Link
US (1) US6255329B1 (pt)
EP (1) EP1093369B1 (pt)
JP (1) JP2002520273A (pt)
KR (1) KR100557692B1 (pt)
CN (1) CN1230168C (pt)
AR (1) AR019896A1 (pt)
AT (1) ATE228365T1 (pt)
AU (1) AU762128B2 (pt)
BG (1) BG64972B1 (pt)
BR (1) BR9911768A (pt)
CA (1) CA2336833C (pt)
CZ (1) CZ294087B6 (pt)
DE (2) DE19830201A1 (pt)
DK (1) DK1093369T3 (pt)
EA (1) EA003142B1 (pt)
EE (1) EE04296B1 (pt)
ES (1) ES2183583T3 (pt)
HK (1) HK1037976A1 (pt)
HU (1) HUP0103922A3 (pt)
ID (1) ID27776A (pt)
IL (1) IL140603A0 (pt)
MY (1) MY117969A (pt)
NO (1) NO20010064L (pt)
NZ (1) NZ509729A (pt)
PL (1) PL195043B1 (pt)
PT (1) PT1093369E (pt)
RS (1) RS49795B (pt)
SK (1) SK284923B6 (pt)
TR (1) TR200100146T2 (pt)
TW (1) TW592698B (pt)
WO (1) WO2000002542A2 (pt)
YU (1) YU401A (pt)
ZA (1) ZA200100090B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006162A1 (de) * 1998-07-27 2000-02-10 Boehringer Ingelheim Pharma Kg Mittel mit antidepressiver wirkung, mit pramipexol und einem weiteren antidepressivum
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
US20060281797A1 (en) * 2001-12-11 2006-12-14 University Of Virginia Patent Foundation Neurorestoration with R(+) Pramipexole
PL374310A1 (en) * 2001-12-11 2005-10-03 University Of Virginia Patent Foundation Use of pramipexole to treat amyotrophic lateral sclerosis
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
CA2554616A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
ES2334061T3 (es) * 2005-08-15 2010-03-04 University Of Virginia Patent Foundation Neurorrestauracion con pramipexol r(+).
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
ATE537826T1 (de) 2006-05-16 2012-01-15 Knopp Neurosciences Inc Zusammensetzungen aus r(+)- und s(-)-pramipexol sowie verfahren zu ihrer anwendung
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
US8519148B2 (en) 2007-03-14 2013-08-27 Knopp Neurosciences, Inc. Synthesis of chirally purified substituted benzothiazole diamines
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
US20110190356A1 (en) * 2008-08-19 2011-08-04 Knopp Neurosciences Inc. Compositions and Methods of Using (R)- Pramipexole
EP2341912B1 (en) 2008-09-05 2014-01-22 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (adhd)
CA2760527A1 (en) * 2009-04-30 2010-11-04 Supernus Pharmaceuticals, Inc. Method of treatment of depression
WO2013096816A1 (en) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
EP2812074B1 (en) 2012-02-08 2023-05-10 Supernus Pharmaceuticals, Inc. Modified release formulations of viloxazine
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
PT3019167T (pt) 2013-07-12 2021-03-04 Knopp Biosciences Llc Tratamento de níveis elevados de eosinófilos e/ou basófilos
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
US9642840B2 (en) 2013-08-13 2017-05-09 Knopp Biosciences, Llc Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
AU2014306597B2 (en) 2013-08-13 2018-05-17 Knopp Biosciences Llc Compositions and methods for treating chronic urticaria
CN110730662A (zh) 2017-04-10 2020-01-24 才思治疗公司 用于治疗共核蛋白病的nk1-拮抗剂组合和方法
KR20200026920A (ko) 2017-06-30 2020-03-11 체이스 테라퓨틱스 코포레이션 우울증을 치료하기 위한 nk-1 길항제 조성물 및 우울증 치료에 사용하는 방법
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
EP0186087B1 (de) * 1984-12-22 1989-08-23 Dr. Karl Thomae GmbH Tetrahydro-benzthiazole, deren Herstellung und deren Verwendung als Zwischenprodukte oder als Arnzneimittel
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
JP3118467B2 (ja) * 1996-03-29 2000-12-18 ファイザー インク． ５―ｈｔ１ａおよび／または５―ｈｔ１ｄ受容体の選択的（アンタ）アゴニストとしてのベンジル（イデン）―ラクタム誘導体、その調製法及びその使用法
EP0942732B1 (en) * 1996-12-02 2004-11-17 MERCK SHARP & DOHME LTD. Use of nk-1 receptor antagonists for treating movement disorders
EP1047436B1 (en) * 1998-01-13 2009-10-21 Synchroneuron, LLC N-acetylhomotaurinates for use in treating hyperkinesias

Also Published As

Publication number Publication date
EP1093369B1 (de) 2002-11-27
NO20010064D0 (no) 2001-01-05
KR100557692B1 (ko) 2006-03-07
SK112001A3 (en) 2001-10-08
AU5030399A (en) 2000-02-01
EA200100084A1 (ru) 2001-08-27
RS49795B (sr) 2008-06-05
CZ200177A3 (en) 2001-06-13
BG105112A (en) 2001-10-31
AR019896A1 (es) 2002-03-20
ID27776A (id) 2001-04-26
JP2002520273A (ja) 2002-07-09
EP1093369A2 (de) 2001-04-25
HUP0103922A2 (hu) 2002-03-28
PL195043B1 (pl) 2007-08-31
EE200100014A (et) 2002-06-17
MY117969A (en) 2004-08-30
NO20010064L (no) 2001-03-02
HK1037976A1 (en) 2002-03-01
CA2336833A1 (en) 2000-01-20
DK1093369T3 (da) 2002-12-16
PT1093369E (pt) 2003-03-31
AU762128B2 (en) 2003-06-19
KR20010079491A (ko) 2001-08-22
DE59903556D1 (de) 2003-01-09
US6255329B1 (en) 2001-07-03
ZA200100090B (en) 2002-04-04
BG64972B1 (bg) 2006-11-30
PL345842A1 (en) 2002-01-14
CA2336833C (en) 2008-09-23
EA003142B1 (ru) 2003-02-27
YU401A (sh) 2003-10-31
CN1230168C (zh) 2005-12-07
ES2183583T3 (es) 2003-03-16
WO2000002542A3 (de) 2000-06-22
ATE228365T1 (de) 2002-12-15
WO2000002542A2 (de) 2000-01-20
BR9911768A (pt) 2001-04-03
SK284923B6 (sk) 2006-02-02
NZ509729A (en) 2003-06-30
CN1308533A (zh) 2001-08-15
TW592698B (en) 2004-06-21
CZ294087B6 (cs) 2004-10-13
EE04296B1 (et) 2004-06-15
DE19830201A1 (de) 2000-01-13
TR200100146T2 (tr) 2001-07-23
HUP0103922A3 (en) 2002-08-28

Similar Documents

Publication Publication Date Title
IL140603A0 (en) Agents with an antidepressive effect
IL139145A0 (en) New use
AU138171S (en) Goggles
GB9818914D0 (en) Use
GB9814640D0 (en) New use
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
EP1005862A4 (en) ANTI-CHLAMYDIA MEDIUM
GB9810630D0 (en) Retaining components
GB9808496D0 (en) Resistance-monitoring arrangement
HUP0105165A3 (en) Lichting arrangement
GB9807503D0 (en) Use
GB9828004D0 (en) Use
GB9817064D0 (en) New use
GB2335259B (en) An explosion-suppressing structure
GB2339003B (en) Movement-damping arrangements
GB9826348D0 (en) Advance arrangement
GB9817911D0 (en) New use
GB2337526B (en) Easy rockeries
PL324932A1 (en) Mould-killing agent
GB9823217D0 (en) Quick quion
TW348390U (en) Auto-bating device with multi-hooks
CA83191S (en) Dickie
GB9808779D0 (en) Concept one
GB9805590D0 (en) Use
GB9828003D0 (en) Use

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees